Degree/ Diploma in Pharmacy from a recognized university with MPC Registration
One year experience in managing drug store in a reputed hospital/ health centre recognized by govt candidate.
Applications are invited for the following newly created posts and various posts already vacant in the newly created Urban Primary Health Center in Karur district on a contractual basis.
M.Sc, MS Pharm, M.Tech in Biomedical Engineering, Medical Devices, Bioelectronics, Life Sciences with a consistently good academic record with a minimum 60% aggregate or 6.75 CGPA
Candidates having Bachelors degree or Integrated MSc in Plant biology/Botany/Genetics/ Biochemistry/ Biotechnology/ Agriculture/life sciences/ Bioinformatics are eligible to apply.
Students with B.E/B.Tech/M.Sc./M.Tech./M.VSc./MBA in Biotechnology/ Bioinformatics and students admitted under DBT PG teaching program in Biotechnology.
Pharm.D or Ph.D. those candidates who have submitted Ph.D. thesis and Viva- Voce is awaited are also eligible for the interview. qualification recognized by PCI with a B.Pharm. from an institution approved by PCI under section 12 of Pharmacy Act, 1948.
Masters Degree in Biochemistry, Immunology, Biotechnology, Life science or related fields. NET-JRF or equivalent National-Level fellowship examination qualification is desirable
Full Time Science Graduate (from a recognized University/Institute with aggregate of 60% marks) in Chemistry/Biochemistry/Biological Chemistry/Analytical chemistry
Experience in review of HPLC, GC, LCMS calibration data & Analytical Data review &Review of Analytical Method Validations, Method Transfers, Protocols & Reports.
Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally.
The U.S. Food and Drug Administration (FDA) approved a new indication for Empaveli (pegcetacoplan) injection to treat adults and children aged 12 years and older with C3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN), two rare kidney diseases that can cause kidney failure. This will be the first medication approved for children with C3G and the first medication approved for the treatment of adults and children with primary IC-MPGN.
Should possess minimum M.Sc / B.Tech / BE /MCA / MPH / B.Pharm/BAMS/ BSMS/ MD in AYUSH or equivalent qualifications in relevant subject with relevant experience (minimum 5 years) in managing any international/National registry, training in regulatory guidelines related to Biomedical and Health Research.
B.Pharmacy from recognized Institute OR 10 +12 with Science Stream (Physics, Chemistry, Biology) from a recognized Board Approved Diploma in Pharmacy from an Institute recognized by the Pharmacy Council of India